Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2016 - 2025)

Collegium Pharmaceutical (COLL) has 5 years of Other Non-Current Liabilities data on record, last reported at $19000.0 in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 99.54% year-over-year to $19000.0; the TTM value through Sep 2025 reached $19000.0, down 99.54%, while the annual FY2024 figure was $1.2 million, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $19000.0 in Q3 2025 per COLL's latest filing, down from $38000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.1 million in Q3 2024 and bottomed at $19000.0 in Q3 2025.